Modeling the relative risk of incidence and mortality of select vaccine-preventable diseases by wealth group and geographic region in Ethiopia.
Journal
PLOS global public health
ISSN: 2767-3375
Titre abrégé: PLOS Glob Public Health
Pays: United States
ID NLM: 9918283779606676
Informations de publication
Date de publication:
2022
2022
Historique:
entrez:
13
3
2023
pubmed:
1
1
2022
medline:
1
1
2022
Statut:
ppublish
Résumé
Immunization is one of the most effective public health interventions, saving millions of lives every year. Ethiopia has seen gradual improvements in immunization coverage and access to child health care services; however, inequalities in child mortality across wealth quintiles and regions remain persistent. We model the relative distributional incidence and mortality of four vaccine-preventable diseases (VPDs) (rotavirus diarrhea, human papillomavirus, measles, and pneumonia) by wealth quintile and geographic region in Ethiopia. Our approach significantly extends an earlier methodology, which utilizes the population attributable fraction and differences in the prevalence of risk and prognostic factors by population subgroup to estimate the relative distribution of VPD incidence and mortality. We use a linear system of equations to estimate the joint distribution of risk and prognostic factors in population subgroups, treating each possible combination of risk or prognostic factors as computationally distinct, thereby allowing us to account for individuals with multiple risk factors. Across all modeling scenarios, our analysis found that the poor and those living in rural and primarily pastoralist or agrarian regions have a greater risk than the rich and those living in urban regions of becoming infected with or dying from a VPD. While in absolute terms all population subgroups benefit from health interventions (e.g., vaccination and treatment), current unequal levels and pro-rich gradients of vaccination and treatment-seeking patterns should be redressed so to significantly improve health equity across wealth quintiles and geographic regions in Ethiopia.
Identifiants
pubmed: 36910428
doi: 10.1371/journal.pgph.0000819
pmc: PMC10004450
mid: NIHMS1872639
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : NIAID NIH HHS
ID : T32 AI007358
Pays : United States
Déclaration de conflit d'intérêts
Competing interests: The authors have declared that no competing interests exist.
Références
Arch Gynecol Obstet. 2012 Mar;285(3):771-7
pubmed: 22159694
Lancet. 2013 Apr 20;381(9875):1405-1416
pubmed: 23582727
Vaccine. 2021 May 18;39(21):2894-2900
pubmed: 33863575
Cochrane Database Syst Rev. 2009 Oct 07;(4):CD004977
pubmed: 19821336
Int J Epidemiol. 2009 Feb;38(1):192-205
pubmed: 19188207
J Health Popul Nutr. 2015 Sep 18;33:18
pubmed: 26825796
BMC Pediatr. 2014 Apr 14;14:102
pubmed: 24731601
Bull World Health Organ. 2008 May;86(5):408-16
pubmed: 18545744
Vaccine. 2008 Aug 19;26 Suppl 12:M80-8
pubmed: 18945417
Int J Epidemiol. 2010 Apr;39 Suppl 1:i75-87
pubmed: 20348131
Wkly Epidemiol Rec. ;92(17):205-27
pubmed: 28459148
Pan Afr Med J. 2017 Jun 09;27(Suppl 2):5
pubmed: 28983393
Lancet. 2015 Dec 5;386(10010):2287-323
pubmed: 26364544
Lancet. 2008 Jan 19;371(9608):243-60
pubmed: 18207566
Health Aff (Millwood). 2018 Feb;37(2):316-324
pubmed: 29401021
Int J Health Sci (Qassim). 2019 May-Jun;13(3):4-9
pubmed: 31123433
BMC Public Health. 2020 Sep 7;20(1):1365
pubmed: 32894099
Vaccine. 2008 Aug 19;26 Suppl 11:L16-36
pubmed: 18945400
Sex Transm Dis. 1993 Sep-Oct;20(5):274-8
pubmed: 8235925
Elife. 2021 Jul 13;10:
pubmed: 34253291
Lancet. 2021 Jan 30;397(10272):398-408
pubmed: 33516338
BMC Med. 2018 Jul 4;16(1):102
pubmed: 29970074
Am J Epidemiol. 2003 Feb 1;157(3):218-26
pubmed: 12543621
Int J Epidemiol. 2010 Apr;39 Suppl 1:i48-55
pubmed: 20348126
BMC Public Health. 2014 Apr 23;14:395
pubmed: 24758243
Epidemiol Infect. 2012 Aug;140(8):1343-55
pubmed: 22583474